Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board -- Ignore unavailable to you. Want to Upgrade?

To: ferd98bull who wrote (1270)	11/4/2015 11:10:39 AM
From: statesidereport	Read Replies (2) \| Respond to of 1728

This "good news" just delayed the start of enrollment from early in the 4thQ (per their Sept Powerpoint deck on their website that says enrollment will start in early Q4) to late 4thQ 2015/early 2016. Nice little bit of trickery LOL. stateside

To: ferd98bull who wrote (1270)	11/4/2015 11:31:46 AM
From: ayeyou	Respond to of 1728

Outstanding !! I am liking that a lot. This is the phrase that I was really hoping to see.... The clinical trial protocol has the provision to allow testing of the vaccine in selected patients with other cancers as well, including prostate, ovarian, pancreas, lung and bladder cancers among others. I know that BCT had applied to have the trials include other cancer forms in their trials but was unsure whether they would get that approval. Now BCT has the ability to really test the BriaVax vaccine against numerous types of cancer and have the results be meaningful in an industry standard human trial. That fact creates a huge bluesky opportunity here for BCT because if this trial results in successful treatment of not just breast cancer but other cancers as well there will be no telling what will happen to share price. BCT already has shown that Briavax had a hugely beneficial effect on a brain tumour that one of the last trial patients had. If they can document similar results this is the potential market according to BCT Investor presentation. I include a timeline from BCT as well. BCT is just about to get rolling guys , pretty exciting stuff not just from an investment angle but exciting to be a small part of something that could become such a huge asset to the medical profession in the fight against cancer. I love owning this stock.